Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Nano-X Imaging Ltd.NASDAQ: NNOX

Gross Profit · Q4 FY2025 · quarter ended Dec 2025

Gross profit remains negative

Q4 FY2025 gross profit was -$3.62M, compared with -$2.89M a year earlier. Trailing-twelve-month gross profit was -$12.79M.

Context

  • Gross profit amounted to 98.2% of revenue in FY2025, up 4.2 pp from a year earlier.
  • Gross profit grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near -$3.62M or moves back toward the trailing-twelve-month quarterly average of -$3.2M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
-$3.62M-25.5% QoQ
Last fiscal yearDec 2025
-$12.79M-20.5% YoY
LTMDec 2025
-$12.79M-19.4% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-25.2%——
1 year-20.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
(12.79M) USD
Year-over-year change
-20.5%

Gross Profit vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 gross profit of -$12.79M is the lowest of the 11 companies compared; the peer median is $35.87M.
  • Its year-over-year change of -19.4% is the 10th highest of 11, against a peer median of +12.3%.
  • Gross profit amounts to 98.2% of revenue for NNOX, versus a peer median of 73.4%.
NNOX Competitors Peer median
Gross Profit for NNOX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INGNInogen, Inc.LTM Mar 2026$171.29M +9.3%+2.6%48.7%
HCATHealth Catalyst, Inc.LTM Mar 2026$139.1M -1.2%-7.9%46.0%
QTRXQuanterix CorporationLTM Mar 2026$63.93M -19.3%+12.6%44.1%
OMOutset Medical, Inc.LTM Mar 2026$47.78M +15.4%+37.9%40.6%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$38.18M +38.8%+55.6%85.1%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$33.55M +21.0%+39.9%75.7%
MXCTMaxCyte, Inc.LTM Mar 2026$26.06M -14.5%-11.9%80.7%
PROFProfound Medical Corp.LTM Mar 2026$13.41M +43.6%+56.6%71.1%
HSDTSolana CompanyLTM Mar 2026$9.03M +6284.9%+157.3%94.2%
CATXPerspective Therapeutics, Inc.LTM Mar 2026-$3.03M -150.0%—489.8%
NNOXNano-X Imaging Ltd.LTM Dec 2025-$12.79M -19.4%—98.2%
Peer median (excluding NNOX) $35.87M+12.3%+37.9%73.4%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.3M8.58M9.91M11.28M13.02M
Cost of Revenue2.82M15.46M16.5M21.89M25.81M
Gross Profit(1.51M)(6.88M)(6.59M)(10.61M)(12.79M)
Gross Margin-116.0%-80.2%-66.6%-94.0%-98.2%
Research & Development17.12M26.51M26.05M20.18M19.24M
Selling, General & Admin41.74M45.63M28.39M25.75M27.1M
Operating Expenses60.05M72.33M56M46.14M47.91M
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
EBITDA(59.27M)(75.7M)(47.69M)(45.01M)(49M)
EBITDA Margin-4544.9%-882.4%-481.5%-398.9%-376.3%
Operating Income(61.56M)(109.71M)(62.59M)(56.75M)(60.7M)
Operating Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%
Interest Income0789K1.65M2.87M1.42M
Interest Expense288K0000
Other Income / Expenses(288K)(14.67M)1.47M2.87M(16.11M)
Income Before Tax(61.85M)(108.92M)(61.12M)(53.87M)(76.81M)
Pre-Tax Margin-4742.8%-1269.8%-617.0%-477.5%-589.9%
Income Tax Expense(48K)(3.68M)(339K)(358K)(1.79M)
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Net Margin-4739.1%-1226.9%-613.6%-474.3%-576.1%
EPS (Basic)(1.28)(2.01)(1.08)(0.91)(1.16)
EPS (Diluted)(1.28)(2.01)(1.08)(0.91)(1.16)
Weighted Avg Shares48.22M52.24M56.37M58.62M64.79M
Weighted Avg Shares (Diluted)48.22M52.24M56.37M58.62M64.79M

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.